Aquestive Therapeutics (AQST) Tax Provisions (2023 - 2024)
Aquestive Therapeutics (AQST) recorded quarterly Tax Provisions of -$14000.0 in Q4 2024, down 113.86% quarter-over-quarter from $101000.0 in Q4 2023, and down 113.86% on a YoY basis from $101000.0 in Q1 2024.
Aquestive Therapeutics (AQST) Tax Provisions (2023 - 2024) Analysis & Trends
Aquestive Therapeutics' Tax Provisions history runs 2 years deep, the most recent figure standing at -$14000.0 for Q4 2024.
- In Q4 2024, Tax Provisions fell 113.86% year-over-year to -$14000.0; the TTM figure through Mar 2025 stood at -$14000.0 (down 105.71% YoY), while the FY2024 annual figure was -$14000.0, down 105.71% from the prior year.
- Tax Provisions was -$14000.0 for Q4 2024 at Aquestive Therapeutics, down from $101000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $284000.0 in Q2 2023 to a low of -$140000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -3.57 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 48.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -9.44 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 37.99 Mn |
| 10 | Aquestive Therapeutics | 488.60 Mn | 377.87 Mn | 10.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -14,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | -140,000.00 |
| Jun 30, 2023 | 284,000.00 |